icon
0%

Colgate-Palmolive Company CL - News Analyzed: 8,770 - Last Week: 100 - Last Month: 400

β‡— Colgate-Palmolive Company CL's Performance in Biotech Market amidst Stakeholders' Varied Actions and Analysts' Reduced Price Targets

Colgate-Palmolive Company CL's Performance in Biotech Market amidst Stakeholders' Varied Actions and Analysts' Reduced Price Targets
Resona Asset Management Co. Ltd. and Aviva PLC among others have significantly increased their stake in Colgate-Palmolive Company while Bank of Montreal has lowered its holdings. Jim Cramer suggests company must acquire somebody. Its ongoing sustainability efforts led to stock decline of 13% however, after surpassing its Q3 earnings yet lowering sales outlook, the valuation is under evaluation. Additionally, despite decreased sales forecast and ongoing consumer weakness, Colgate-Palmolive partnerships and acquisitions, such as working with Erthos for sustainable packaging, suggest its growth priorities remain steady. Notably, analysts are consistently re-adjusting the company's price target, with Barclays, Morgan Stanley, JP Morgan and UBS reducing it in response to market trends. They further stress on the importance of keeping an eye on Colgate-Palmolive's earning calls and Q3 report, given its key financials impact on predictions for the company's stock price.

Colgate-Palmolive Company CL News Analytics from Sun, 14 Sep 2025 07:00:00 GMT to Sat, 08 Nov 2025 14:40:49 GMT - Rating 4 - Innovation 6 - Information 7 - Rumor -3

The email address you have entered is invalid.